SecBot SecBot

TRML

TOURMALINE BIO INC
No price
New fund stakes
0
Q4 2025 13F · 9 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score
Strongest NEUTRAL The 13F cluster for Tourmaline Bio (TRML) shows a mixed institutional picture for Q3 2025: two buyers (led…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsBEARISH

    Q4 2025: 0 added (0 new), 9 trimmed or exited.

Who's buying

13F· Q4 2025
0
new positions
9
exits
FundMoveSharesValue
VANGUARD GROUP INCEXIT0$0.00
BlackRock, Inc.EXIT0$0.00
STATE STREET CORPEXIT0$0.00
MORGAN STANLEYEXIT0$0.00
Magnetar Financial LLCEXIT0$0.00
FIL LtdEXIT0$0.00
GEODE CAPITAL MANAGEMENT, LLCEXIT0$0.00
GOLDMAN SACHS GROUP INCEXIT0$0.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 11, 2026
Earnings date
TRML Q2 2026 Earnings Scheduled, 2026-08-11
Apr 30, 2026
Earnings date
TRML Q1 2026 Earnings Scheduled, 2026-04-30
Mar 11, 2026
Earnings date
TRML Q4 2025 Earnings After Market Close, 2026-03-11
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 11, 2026 Earnings calendar
TRML Q2 2026 Earnings Scheduled, 2026-08-11
Jun 11, 2026 SEC
The 13F cluster for Tourmaline Bio (TRML) shows a mixed institutional picture for Q3 2025: two buyers (led by Schwab…
INST-CLUSTER · Impact 3/10
Dec 31, 2025 Inst.
VANGUARD GROUP INC · EXIT
0 shares ($0.00)
Dec 31, 2025 Inst.
BlackRock, Inc. · EXIT
0 shares ($0.00)

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All TRML filing & press-release reports (1)